Last Price$60.00.0%
Market Cap$2,336.7M
N/A
Industry median - 13.4%
5Y Historical average - N/A
65.3%
Industry median - 0.3%
5Y Historical average - 924.9%
(5.9%)
Industry median - (20.6%)
5Y Historical average - 908.2%
33.2%
Industry median - (1.7%)
5Y Historical average - 2,147.0%
LBPH Growth Rating
LBPH Growth rating
5.9
LBPH Growth rating performance
LBPH Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with LBPH Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$2,336.7M | 5.9 | N/A | N/A | N/A | N/A | (5.9%) | (6.9%) | N/A | 33.2% | |
$124.8B | 6.9 | 21.5% | 11.5% | 8.6% | N/A | N/A | (962.4%) | N/A | N/A | |
$77.0B | 5.6 | 12.6% | 8.3% | 2.4% | 16.1% | 10.3% | 3.1% | 12.5% | (5.7%) | |
$34.4B | 6.3 | 106.9% | 127.3% | 76.3% | (9.7%) | (57.5%) | (132.2%) | N/A | (70.8%) | |
$30.7B | 5.4 | 59.2% | 23.0% | 28.6% | (23.2%) | (38.5%) | (26.5%) | (36.7%) | N/A | |
$24.0B | 6.2 | 90.9% | (28.0%) | (28.0%) | 36.5% | N/A | (182.9%) | (3.1%) | N/A | |
$14.5B | 4.0 | 4.5% | (3.8%) | 35.4% | (19.0%) | (9.0%) | 144.6% | 10.7% | (7.3%) | |
$13.8B | 7.5 | 14.7% | 23.6% | 9.1% | N/A | 25.6% | 6.8% | N/A | 44.5% | |
$13.4B | 7.1 | 10.8% | 17.8% | 10.0% | N/A | 152.8% | 48.9% | N/A | 820.5% | |
$13.3B | 6.1 | (100.0%) | N/A | N/A | (0.9%) | (92.8%) | 11.4% | 44.6% | 84.8% | |
$1,846.9M | 5.9 | 50.5% | 50.5% | 50.7% | 25.3% | 20.9% | (35.6%) | 3.3% | (43.8%) |
FAQ
What is the Longboard Pharmaceuticals, Inc. (LBPH) revenue growth?
The Longboard Pharmaceuticals, Inc. (LBPH) revenue growth is N/A, which is lower than the industry median of 13.4% and the 5-year historical average of N/A.
What is the Longboard Pharmaceuticals, Inc. (LBPH) operating income growth?
The Longboard Pharmaceuticals, Inc. (LBPH) operating income growth is 65.3%, compared to the industry median of 0.3% and the 5-year historical average of 924.9%.
What is the Longboard Pharmaceuticals, Inc. (LBPH) EPS (Earnings Per Share) growth?
The Longboard Pharmaceuticals, Inc. (LBPH) EPS growth is (5.9%), compared to the industry median of (20.6%) and the 5-year historical average of 908.2%.
What is the Longboard Pharmaceuticals, Inc. (LBPH) Free Cash Flow (FCF) growth?
The Longboard Pharmaceuticals, Inc. (LBPH) Free Cash Flow growth is 33.2%, compared to the industry median of (1.7%) and the 5-year historical average of 2,147.0%.